News about Drug Discovery & Development

Yapan Bio adds process development facility

Expands capacity and capabilities in large molecule therapeutics

Drug Discovery & Development | 19/10/2022 | By Sudeep Soparkar |  756

Baxter Pharma opens global pharma R&D Centre in Ahmedabad

The 20,500-square-foot, state-of-the-art R&D Centre features an array of sophisticated equipment and research labs that will focus on pharmaceutical product development

Drug Discovery & Development | 18/10/2022 | By Sudeep Soparkar |  2648

Piramal Pharma Solutions launches ADCelerate

ADCelerate is a new, branded solution for antibody-drug conjugate drug development

Drug Discovery & Development | 13/10/2022 | By Sudeep Soparkar |  523

IIL to invest Rs700 Cr in Hyd for new animal vaccine facility

The facility is intended to be a state-of-art fully integrated biosafety level 3 (BSL-3) for Drug substance (DS) production and respective fill-finish

Drug Discovery & Development | 11/10/2022 | By Sudeep Soparkar |  844

Eisai completes construction of new injection/research building at Kawashima Industrial Park, Japan

Eisai Medicine Innovation Technology Solutions will be Eisai's global base for formulation and modality research

Drug Discovery & Development | 06/10/2022 | By Sudeep Soparkar |  942

WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

New facility expands integrated drug product R&D and manufacturing services to global customers

Drug Discovery & Development | 27/09/2022 | By Sudeep Soparkar |  722

Rely+On Virkon from LANXESS effective against monkeypox virus

Effectiveness of Rely+On Virkon scientifically proven
Disinfection a key to help prevent transmission
Hygiene best practices essential

Drug Discovery & Development | 26/09/2022 | By Sudeep Soparkar |  806

Merck India inaugurates R&D Excellence Centre in Bengaluru

Since 2020 the Excellence centre has onboarded around 300 employees and will continue its expansion over the next two years

Drug Discovery & Development | 02/09/2022 | By Sudeep Soparkar |  1243

CELLINK to establish CoE in India with IISc

The Centre of Excellence (CoE) will be focused on advancing research across heart, bone, cartilage and cancer research through the use of 3D bioprinting.

Drug Discovery & Development | 26/08/2022 | By Sudeep Soparkar |  493

AD Ports Group, Hayat Biotech partner to upgrade logistics solutions

The facilities will produce several vital biopharmaceutical products, including the Hayat-Vax vaccine, the first indigenously produced COVID-19 vaccine in the UAE

Drug Discovery & Development | 15/07/2022 | By Sudeep Soparkar |  848